1. Home
  2. RMT vs RGNX Comparison

RMT vs RGNX Comparison

Compare RMT & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMT
  • RGNX
  • Stock Information
  • Founded
  • RMT 1993
  • RGNX 2008
  • Country
  • RMT United States
  • RGNX United States
  • Employees
  • RMT N/A
  • RGNX N/A
  • Industry
  • RMT Investment Managers
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RMT Finance
  • RGNX Health Care
  • Exchange
  • RMT Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • RMT 460.2M
  • RGNX 445.5M
  • IPO Year
  • RMT N/A
  • RGNX 2015
  • Fundamental
  • Price
  • RMT $10.17
  • RGNX $8.93
  • Analyst Decision
  • RMT
  • RGNX Strong Buy
  • Analyst Count
  • RMT 0
  • RGNX 8
  • Target Price
  • RMT N/A
  • RGNX $28.50
  • AVG Volume (30 Days)
  • RMT 111.5K
  • RGNX 690.5K
  • Earning Date
  • RMT 01-01-0001
  • RGNX 08-07-2025
  • Dividend Yield
  • RMT 7.37%
  • RGNX N/A
  • EPS Growth
  • RMT N/A
  • RGNX N/A
  • EPS
  • RMT 1.49
  • RGNX N/A
  • Revenue
  • RMT N/A
  • RGNX $155,782,000.00
  • Revenue This Year
  • RMT N/A
  • RGNX $260.25
  • Revenue Next Year
  • RMT N/A
  • RGNX N/A
  • P/E Ratio
  • RMT $6.18
  • RGNX N/A
  • Revenue Growth
  • RMT N/A
  • RGNX 74.95
  • 52 Week Low
  • RMT $7.67
  • RGNX $5.04
  • 52 Week High
  • RMT $9.51
  • RGNX $13.48
  • Technical
  • Relative Strength Index (RSI)
  • RMT 66.95
  • RGNX 54.35
  • Support Level
  • RMT $9.56
  • RGNX $8.65
  • Resistance Level
  • RMT $9.85
  • RGNX $9.19
  • Average True Range (ATR)
  • RMT 0.15
  • RGNX 0.49
  • MACD
  • RMT 0.04
  • RGNX 0.08
  • Stochastic Oscillator
  • RMT 86.75
  • RGNX 81.36

About RMT Royce Micro-Cap Trust Inc.

Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector including auto components, automobiles, diversified consumer services, hotels, restaurants and leisure, household durables, internet and catalog retail, leisure products, media, multiline retail, textiles, apparels, and luxury goods, Consumer staples sector including beverages, food, and staples retailing, food products, and personal products, Energy sector including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors including healthcare, financials, industrials, IT, telecommunications, and materials.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: